Discover Tenders by Foundry Mould Forming Machinery Sector

Find the most relevant tenders for Foundry Mould Forming Machinery. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Foundry Mould Forming Machinery tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Foundry Mould Forming Machinery tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab Exclusively In Dafo Injection Solution Atc L04Aa23 Obo For The Period 01 09 24 31 08 26

Deadline: 05 Jul 2026

Germany

Ref. No.: 7164900

EMD:Ref Document

Bid Value: Ref Document

261 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V Open House Model

Deadline: 01 Jul 2026

Germany

Ref. No.: 7139372

EMD:Ref Document

Bid Value: Ref Document

257 Days Left

Devcom Army Research Laboratory Broad Agency Announcement For Foundational Research

Deadline: 20 Nov 2027

United States

Ref. No.: 7135310

EMD:Ref Document

Bid Value: Ref Document

764 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Evolocumab C10Ax13 Within The Framework Of A So Called Open House Model

Deadline: 01 Jul 2026

Germany

Ref. No.: 7110598

EMD:Ref Document

Bid Value: Ref Document

257 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lanthanum Iii Carbonate Chewable Tablets Only V03Ae03 Within The Framework Of A So

Deadline: 01 Jul 2026

Germany

Ref. No.: 7110380

EMD:Ref Document

Bid Value: Ref Document

257 Days Left

Health And Social Care Network Hscn Access Services Extension

Deadline: 23 May 2028

Great Britain

Ref. No.: 7109677

EMD:Ref Document

Bid Value: Ref Document

949 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Triptorelin Atc L02Ae04 Obo For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7066413

EMD:Ref Document

Bid Value: Ref Document

261 Days Left

Pre Qualified Builders List Residential

Deadline: 30 Jun 2026

Australia

Ref. No.: 7064966

EMD:Ref Document

Bid Value: Ref Document

256 Days Left

Open House Discount Contracts 2024 09

Deadline: 31 Aug 2026

Germany

Ref. No.: 7034479

EMD:Ref Document

Bid Value: Ref Document

318 Days Left

Hvdc Based Grid Architectures For Reliable And Resilient Widespread Hybrid Ac Dc Transmission Systems

Deadline: 31 Mar 2026

France

Ref. No.: 7016853

EMD:Ref Document

Bid Value: Ref Document

165 Days Left

Defense Logistics Information Research Dlir

Deadline: 01 Sep 2026

United States

Ref. No.: 7005758

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V Open House Model

Deadline: 01 Jul 2026

Germany

Ref. No.: 6956974

EMD:Ref Document

Bid Value: Ref Document

257 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Rivaroxaban Atc B01Af01 In The Active Strength 2 5 Mg Per Divided Oral Dosage Form

Deadline: 27 Jun 2026

Germany

Ref. No.: 6914003

EMD:Ref Document

Bid Value: Ref Document

253 Days Left

Efficient Water Splitting Via A Flexible Solar Powered Hybrid Thermochemical Sulphur Dioxide Depolarized Electrolysis Cycle

Deadline: 31 Dec 2026

Germany

Ref. No.: 6881134

EMD:Ref Document

Bid Value: Ref Document

440 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Rivaroxaban Atc B01Af01 In All Strengths Except 2 5 Mg Per Divided Oral Dosage Form

Deadline: 27 Jun 2026

Germany

Ref. No.: 6879610

EMD:Ref Document

Bid Value: Ref Document

253 Days Left

Showing 26011 to 26025 of 26265 results

‹
1
2
...
1732
1733
1734
1735
1736
1737
1738
...
1750
1751
›

Discover Tenders by Foundry Mould Forming Machinery Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Foundry Mould Forming Machinery Sector

Filter Your Search

FREE Trial plan for all new users!